** Shares of Tecan TECN.S rise 7.8% after the Swiss lab automation firm reported mixed FY orders and sales, confirmed 2025 profitability target ahead of full results, and reiterated its medium-term forecast
** It says end-markets are expected to recover gradually, but full normalization is not anticipated in 2026
** "The confirmed outlook and the order intake is likely to prompt a relieved reaction from the market today, therefore, all in all slightly positive," Vontobel analysts says in a note
** Order intake was up 8.6% in H2, bringing FY intake up 3.8% in local currencies
** But sentiment remains mixed, Vontobel says, noting that "volume decrease, together with e.o. costs and FX headwind is weighting strongly on the company"
** FY sales of CHF 882.5 million ($1.1 billion) fell short of IBES estimate of CHF 913.4 million
** Shares are on track for their best day since August 12, 2025, if the gains hold
($1 = 0.7999 Swiss francs)
(Reporting by Marleen Kaesebier)
((marleen.kaesebier@thomsonreuters.com))